FDA Recalls Extended-Release Metformin Due to NDMA Impurities FDA Recalls Extended-Release Metformin Due to NDMA Impurities

The FDA advises voluntary recall of extended-release metformin made by five manufacturers after NDMA contamination found in some batches.News Alerts
Source: Medscape Pharmacist Headlines - Category: Drugs & Pharmacology Tags: Diabetes & Endocrinology News Alert Source Type: news